Webinar – Getting GRIP on MASH after LITMUS
On March 12th, we organised the webinar: Getting GRIP on MASH after LITMUS
During this webinar, our speaker and hosts explored the following topics:
- The usefulness of noninvasive diagnostic methods depends on the prevalence of the disease
- Intervention in lifestyle helps to better stratify patients
- Clinical pathways from primary care or endocrinology clinics improves MASH management
Speakers, hosts, and audience
- Speaker: Prof. Manuel Romero-Gómez
- Hosts: Prof. Manuel Castro Cabezas & Prof. Rick Grobbee
- Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers
Watch the recording here:
Related
Peer Reviewed Publication: LAP-defined Hepatic Steatosis and Cardiometabolic Risk in Rheumatoid Arthritis
LAP-defined Hepatic Steatosis and Cardiometabolic Risk in Rheumatoid Arthritis: A Post-hoc Analysis of the FRANCIS Randomized TrialPatients with rheumatoid arthritis (RA) face an increased risk of cardiovascular disease, driven by a complex in...
Case Study: Accelerating Performance in a Phase III CVOT Rescue Program for a Mid-Size Biotech
Rescuing a Stalled Cardiovascular Outcomes Trial Through Targeted Operational Intervention When a Phase III cardiovascular outcomes trial (CVOT) faced significant enrollment delays and timeline risk, Julius Clinical was engaged to support and acc...
Case Study: Supporting Global Delivery of a Phase III Cardiovascular Outcomes Trial for a Global Top-10 Pharmaceutical Company
Executing a Complex Phase III Diabetes Cardiovascular Outcomes Trial in a High-Risk Population Cardiovascular outcomes trials (CVOTs) in type 2 diabetes present a unique combination of clinical, operational, and regulatory complexity, particularl...